Cardio Diagnostics Quote - CDIO

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.4698

Bid

0.45

Offer

0.4699

Volume

4,455,057

0.4302 Day's Range 0.495

0.19 52 Week Range 2.40

Market Cap

18.999M

Previous Close

0.439

Open

0.47

Last Trade

0.4601

Last Trade Time

Financial Volume

US$ 2,027,023

VWAP

0.454994

Average Volume (3m)

6,472,566

Shares Outstanding

40,439,810

Dividend Yield

PE Ratio

-2.27

Earnings Per Share (EPS)

-0.21

Revenue

17k

Net Profit

-8.38M

Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenet... Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assists in the treatment of cardiovascular disease. Show more

Sector

In Vitro,in Vivo Diagnostics

Industry

In Vitro,in Vivo Diagnostics

Headquarters

Dover, Delaware, USA

Founded

Cardio Diagnostics Holdings Inc is listed in the In Vitro,in Vivo Diagnostics sector of the NASDAQ with ticker CDIO. The last closing price for Cardio Diagnostics was US$0.44. Over the last year, Cardio Diagnostics shares have traded in a share price range of US$ 0.19 to US$ 2.40.

Cardio Diagnostics currently has 40,439,810 shares in issue. The market capitalisation of Cardio Diagnostics is US$17.75 million. Cardio Diagnostics has a price to earnings ratio (PE ratio) of -2.27.

Cardio Diagnostics Expands the Reach of its AI-Driven Precision Cardiovascular Medicine Tests by Partnering with Seven New Provider Organizations

Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an AI-driven Precision Cardiovascular Medicine company, today announced that the Company has partnered with seven new provider organizations...

Cardio Diagnostics Holdings, Inc. Receives Final Medicare Pricing Determination from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests

CMS pricing determination marks a key milestone in gaining broad access to Medicare reimbursement. Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine...

Cardio Diagnostics Holdings, Inc. to Sponsor and Showcase AI-Powered Solutions at the FLAACOs Annual Conference

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-powered precision cardiovascular medicine company, today announced it will sponsor and exhibit at the Florida Association of ACOs (FLAACOs...

Cardio Diagnostics Holdings, Inc. Receives Preliminary Medicare Pricing from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests

Preliminary CMS pricing determination marks a key milestone in gaining broad access to Medicare reimbursement. Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision...

Cardio Diagnostics Holdings Inc. Launches CDIO.AI, A Redesigned Website Enhancing User Experience and Highlighting Our AI-Driven Cardiovascular Solutions

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), a leader in AI-powered precision cardiovascular medicine, today announced the launch of its redesigned website at CDIO.AI. This new site...

Cardio Diagnostics Announces Its Epi+Gen CHD Heart Attack Risk Assessment Test is Now Available at Meijer Supercenter in McHenry, Illinois

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announced today that the Company’s clinical blood test, Epi+Gen CHD is now available at...

Cardio Diagnostics Announces Its Epi+Gen CHD Heart Attack Risk Assessment Test is Now Available at Meijer Supercenter in McHenry, Illinois

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announced today that the Company’s clinical blood test, Epi+Gen CHD is now available at...

Cardio Diagnostics Announces It’s Exhibiting at the 2024 Onsite Employee Health Clinics Forum

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announced today that the Company will sponsor a booth and showcase its groundbreaking...

Cardio Diagnostics Holdings, Inc. Achieves SOC 2 Type I Compliance Certification for Security and Confidentiality

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), a leader in AI-driven precision cardiovascular medicine, today announced the successful completion of its System and Organization Controls (SOC...

Cardio Diagnostics to Participate in the Centers for Medicare and Medicaid Services’ (CMS) Clinical Laboratory Fee Schedule (CLFS) Annual Meeting to Secure Medicare Payment for Its Innovative Tests

Company to recommend pricing for its Epi+Gen CHD and PrecisionCHD tests, and pursue coverage via the Molecular Diagnostic Services (MolDx) program. Cardio Diagnostics Holdings, Inc. (NASDAQ:...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.0295	6.69997728821	0.4403	0.539	0.418	1339460	0.46333443	CS
4	-0.4512	-48.990228013	0.921	0.936999	0.4028	3866978	0.5983414	CS
12	0.0648	16	0.405	1.77	0.2153	6472566	0.73545125	CS
26	0.0803	20.6161745828	0.3895	1.77	0.19	4165764	0.59667563	CS
52	-1.8702	-79.9230769231	2.34	2.4	0.19	2328493	0.65000791	CS
156	-3.7802	-88.9458823529	4.25	8.4999	0.171	3152795	1.610078	CS
260	-3.7802	-88.9458823529	4.25	8.4999	0.171	3152795	1.610078	CS

CDIO - Frequently Asked Questions (FAQ)

What is the current Cardio Diagnostics share price?

The current share price of Cardio Diagnostics is US$ 0.4698

How many Cardio Diagnostics shares are in issue?

Cardio Diagnostics has 40,439,810 shares in issue

What is the market cap of Cardio Diagnostics?

The market capitalisation of Cardio Diagnostics is USD 17.75M

What is the 1 year trading range for Cardio Diagnostics share price?

Cardio Diagnostics has traded in the range of US$ 0.19 to US$ 2.40 during the past year

What is the PE ratio of Cardio Diagnostics?

The price to earnings ratio of Cardio Diagnostics is -2.27

What is the cash to sales ratio of Cardio Diagnostics?

The cash to sales ratio of Cardio Diagnostics is 1.18k

What is the reporting currency for Cardio Diagnostics?

Cardio Diagnostics reports financial results in USD

What is the latest annual turnover for Cardio Diagnostics?

The latest annual turnover of Cardio Diagnostics is USD 17k

What is the latest annual profit for Cardio Diagnostics?

The latest annual profit of Cardio Diagnostics is USD -8.38M

What is the registered address of Cardio Diagnostics?

The registered address for Cardio Diagnostics is 8 THE GREEN, SUITE #12490, DOVER, DELAWARE, 19901

Which industry sector does Cardio Diagnostics operate in?

Cardio Diagnostics operates in the IN VITRO,IN VIVO DIAGNOSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CAPTCaptiVision Inc	US$ 1.024 (133.26%)	246M
QNTMQuantum Biopharma Ltd	US$ 6.70 (110.69%)	78.56M
LTRYLottery com Inc	US$ 0.58 (85.90%)	129.21M
CPIXCumberland Pharmaceutical Inc	US$ 3.7801 (77.47%)	18.49M
INKTMiNK Therapeutics Inc	US$ 12.08 (53.69%)	350.86k
OMGAOmega Therapeutics Inc	US$ 0.1473 (-69.25%)	11.71M
VIRXViracta Therapeutics Inc	US$ 0.0352 (-54.76%)	6.33M
CYNCYNGN Inc	US$ 0.0708 (-39.44%)	137.42M
UPCUniverse Pharmaceuticals Inc	US$ 0.2663 (-36.20%)	1.9M
CSAICloudastructure Inc	US$ 12.98 (-31.68%)	57.03k
NVDANVIDIA Corporation	US$ 118.65 (1.71%)	256.77M
CAPTCaptiVision Inc	US$ 1.024 (133.26%)	246M
PLTRPalantir Technologies Inc	US$ 103.83 (23.99%)	230.5M
RGTIRigetti Computing Inc	US$ 13.71 (1.78%)	159.64M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.1518 (-22.11%)	142.77M